Literature DB >> 22899780

Identification of bacteria directly from positive blood culture samples by DNA pyrosequencing of the 16S rRNA gene.

Maiko Motoshima1, Katsunori Yanagihara1, Yoshitomo Morinaga1, Junichi Matsuda1, Hiroo Hasegawa1, Shigeru Kohno2,3, Shimeru Kamihira1.   

Abstract

Rapid identification of the causative bacteria of sepsis in patients can contribute to the selection of appropriate antibiotics and improvement of patients' prognosis. Genotypic identification is an emerging technology that may provide an alternative method to, or complement, established phenotypic identification procedures. We evaluated a rapid protocol for bacterial identification based on PCR and pyrosequencing of the V1 and V3 regions of the 16S rRNA gene using DNA extracted directly from positive blood culture samples. One hundred and two positive blood culture bottles from 68 patients were randomly selected and the bacteria were identified by phenotyping and pyrosequencing. The results of pyrosequencing identification displayed 84.3 and 64.7 % concordance with the results of phenotypic identification at the genus and species levels, respectively. In the monomicrobial samples, the concordance between the results of pyrosequencing and phenotypic identification at the genus level was 87.0 %. Pyrosequencing identified one isolate in 60 % of polymicrobial samples, which were confirmed by culture analysis. Of the samples identified by pyrosequencing, 55.7 % showed consistent results in V1 and V3 targeted sequencing; other samples were identified based on the results of V1 (12.5 %) or V3 (31.8 %) sequencing alone. One isolate was erroneously identified by pyrosequencing due to high sequence similarity with another isolate. Pyrosequencing identified one isolate that was not detected by phenotypic identification. The process of pyrosequencing identification can be completed within ~4 h. The information provided by DNA-pyrosequencing for the identification of micro-organisms in positive blood culture bottles is accurate and could prove to be a rapid and useful tool in standard laboratory practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899780     DOI: 10.1099/jmm.0.049163-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

2.  Fetal Tissues Tested for Microbial Sterility by Culture- and PCR-Based Methods Can be Safely Used in Clinics.

Authors:  Yakov Vitrenko; Iryna Kostenko; Kateryna Kulebyakina; Alla Duda; Mariya Klunnyk; Khrystyna Sorochynska
Journal:  Cell Transplant       Date:  2016-08-05       Impact factor: 4.064

Review 3.  Commercial multiplex technologies for the microbiological diagnosis of sepsis.

Authors:  Evan E Lebovitz; Peter D Burbelo
Journal:  Mol Diagn Ther       Date:  2013-08       Impact factor: 4.074

4.  Association of host and microbial species diversity across spatial scales in desert rodent communities.

Authors:  Yoni Gavish; Hadar Kedem; Irit Messika; Carmit Cohen; Evelyn Toh; Daniel Munro; Qunfeng Dong; Clay Fuqua; Keith Clay; Hadas Hawlena
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Don't miss the diagnosis of sepsis!

Authors:  Paul E Marik
Journal:  Crit Care       Date:  2014-09-27       Impact factor: 9.097

6.  A simple mathematical model to determine the ideal empirical antibiotic therapy for bacteremic patients.

Authors:  Felipe F Tuon; Jaime L Rocha; Talita M Leite; Camila Dias
Journal:  Braz J Infect Dis       Date:  2014-03-01       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.